This raises the exciting possibility that PPP1R15A inhibition may be a potential therapeutic strategy in obesity with insulin resistance or in advanced states of the natural evolution towards diet-induced diabetes. The gene discussed is PPP1R15A; the disease is obesity due to melanocortin 4 receptor deficiency.